Activity :
Healthcare
Customer :
XLabs
Acquirer :
CIC, Crédit Agricole, BNPP, LCL
Advice :
Thomas Bureau, Maxime Fournely
About Largillière Finance
With offices in Paris, Nantes, Brussels and Geneva, Largillière Finance is an independent investment bank dedicated to assisting managers and shareholders of small and medium-sized companies with their capital transactions: company sales and acquisitions, financing (capital and/or debt), financial engineering (valuation, etc.) and financial strategy.
Fundraising - 2023
The investment bank Largillière Finance has accompanied the XLabs laboratory network, one of the leaders in medical biology in Western France, in setting up structured bank financing with CIC, to support its geographical expansion strategy.
Founded in 1985 by Michel Bendahan, XLabs, headquartered in Cholet (49), is an independent inter-regional network of medical biology laboratories based in the Pays de la Loire and Nouvelle-Aquitaine regions. Historically, the network has developed through external growth, followed by the opening of new sites.
Today, XLabs brings together 10 sampling sites, including a technical platform in Cholet, and relies on an expert team of over 150 employees, including 12 medical biologists, processing 750 dossiers per day (excluding Covid). XLabs has ISO 9001 certification and COFRAC accreditation, which certify the reliability and quality of all analyses performed in the laboratories. It is the only multi-site laboratory with this accreditation in the Pays de la Loire region.
In a market that has grown steadily since the health crisis, XLabs intends to capitalize on its expertise and experienced teams to accelerate its development and consolidate its position as a benchmark in the West of France, as well as in the rest of France.
Consequently, the financing will be used to open new sites and selectively take advantage of external growth opportunities. Through this geographic expansion, XLabs aims to offer a local network for independent, quality and innovative medical biology for the health and well-being of patients.
Michel Bendahan, Founder of XLabs:
“This is an important step in the development of XLabs. We would particularly like to thank the Largillière Finance teams for their support throughout the process. Their perfect understanding of the healthcare market was decisive, enabling us to move forward with confidence alongside them”
Thomas Bureau, Managing Partner at Largillière Finance:
“Thanks to our solid expertise in the healthcare sector, we were able to identify the strengths of XLabs’ innovative project and fulfill our mission: to find the right partners to set up non-dilutive financing adapted to the company’s ambitions within a restrictive regulatory framework. This transaction also reinforces our strong presence in the West of France”.
With more than 35 employees, a strong international presence and nearly 30 operations in 2022, Largillière Finance confirms its leader position in small and midcap in France.
2021 – Fusions & Acquisitions – Opérations Small Cap – Banque d’affaires – France 2021 – Capital investissement – Opérations LBO Small Cap – Banque d’affaires – France
Investment Banking: Growth Dynamics: Silver Trophy 2022 M&A Advisory: Retail & Consumer Goods, FIG, TMT, Industry: 2021 Silver Trophy.About Largillière Finance
With offices in Paris, Nantes, Brussels and Geneva, Largillière Finance is an independent investment bank dedicated to assisting managers and shareholders of small and medium-sized companies with their capital transactions: company sales and acquisitions, financing (capital and/or debt), financial engineering (valuation, etc.) and financial strategy.
À voir aussi
